Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ringer's solution loading to prevent post-ERCP pancreatitis
jRCTs041230145Recruiting
- Sponsor
- Mie University Hospital
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of ringer's solution and diclofenac in post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP) (2 arms), sponsored by Mie University Hospital. Primary endpoint: Incidence rate of post-ERCP pancreatitis. Started May 2024; status: recruiting.
02
Drugs
ringer's solutiondiclofenac
03
Conditions
post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP)
Beyond the preview
Go deeper on jRCTs041230145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041230145.